Perinox developed an industrial installation for animal blood plasma filtration and concentration for a leading multinational company in the production of high-quality spray-dried plasma.
The project integrated biological fluid treatment, storage, concentration, CIP system, SCADA automation and hygienic control to ensure traceability, operational efficiency and process stability in a high-value industrial application.
Animal blood plasma filtration requires solutions capable of treating complex biological fluids, maintaining controlled hygienic conditions and ensuring stable performance before downstream stages such as drying or atomization.
The solution developed by Perinox
Perinox designed and integrated an industrial installation for the management, filtration and concentration of animal blood plasma.
The solution included hygienic storage tanks with temperature control criteria, dedicated systems for product treatment, concentration equipment, a fully integrated CIP system and a SCADA platform adapted to the client’s corporate standards.
This integration enabled centralised supervision of critical variables such as temperature, flow rate, pressure and tank levels, supporting batch consistency and operational control.
Animal blood plasma filtration in industrial processes
Animal blood plasma is a high-value biological fluid that requires demanding treatment conditions due to its composition, sanitary sensitivity and downstream transformation requirements.
In this type of application, filtration is not only a separation step. It is part of a process architecture designed to preserve product quality, control critical variables and prepare the fluid for subsequent concentration, drying or atomization stages.
For this reason, the installation must consider fluid behaviour, hygienic design, production requirements, automation and process traceability from the early engineering stages.
Concentration of high-value biological fluids
Animal blood plasma concentration is a strategic stage for improving process performance and increasing the efficiency of downstream operations.
The installed concentration system helps increase total solids, reduce process variability, improve quality control and prepare the product for later stages such as drying or atomization.
In applications involving high-value biological fluids, concentration must be managed with particular care. Inadequate design can affect product stability, increase batch-to-batch variability or compromise downstream efficiency.
Crossflow filtration in animal blood-derived products
Crossflow filtration is especially relevant in animal blood-derived product applications where complex biological fluids must be separated, concentrated or conditioned without compromising product quality.
In sectors linked to blood and blood-derived products, filtration technologies must be adapted to sensitive matrices with high functional value and strict sanitary requirements.
Technology selection depends on fluid composition, solids concentration, thermal sensitivity, separation objective, operating flow rate, cleaning requirements and industrial scale-up conditions.
In these applications, crossflow membrane filtration works with a flow parallel to the membrane surface, reducing solids build-up and supporting more stable operation over time.
Control of critical variables in complex fluids
Process stability depends on the control of variables such as temperature, pressure, flow rate, concentration, tank levels and hygienic operating conditions.
In complex biological fluids, these variables directly influence product quality, process safety and the efficiency of downstream stages.
When filtration and membrane concentration technologies are incorporated, fouling and permeate flux control becomes especially important to maintain stable operation, reduce downtime and ensure repeatable results.
A well-designed system must maintain performance, cleanliness, stability and traceability during real industrial production cycles.
CIP system, hygienic design and SCADA automation
The integration of a fully connected CIP system was one of the key elements of the project.
The system enables automatic, reproducible and controlled cleaning cycles, reducing downtime and strengthening the microbiological safety of the installation.
In applications involving animal blood plasma, cleaning is part of the sanitary architecture of the process. It directly affects operational reliability, line availability and final product quality.
The SCADA system developed for this project enables centralised installation management and continuous supervision of critical process variables. Full automation improves traceability, reduces manual intervention, enhances batch repeatability and supports alignment with the client’s corporate protocols.
Operational impact of the installation
The installation developed by Perinox improves industrial animal blood plasma management from several perspectives.
It helps optimise total solids before downstream drying or atomization stages, improves process control, reduces operational variability and strengthens sanitary safety through hygienic design, CIP integration and automation.
It also improves traceability and quality control in an application where product consistency is decisive for industrial competitiveness.
Investment criteria for filtration technologies
In high-value industrial processes, technology decisions must be assessed according to production volume, fluid value, operational efficiency, energy consumption, process stability and scale-up capacity.
These factors are especially relevant when working with sensitive raw materials such as animal blood plasma.
Correctly defining investment criteria for filtration technologies makes it possible to select solutions capable of generating real impact on yield, quality, operating costs and process safety.
In this type of application, technology should not be evaluated only by its separation or concentration capacity, but by its integration within a complete industrial solution.
Perinox as a technology partner for blood-derived products
Perinox develops industrial solutions for the treatment of complex fluids, integrating process engineering, equipment design, automation, CIP systems and filtration and concentration technologies.
In sectors such as blood and blood-derived products, this experience makes it possible to design installations adapted to sensitive products, strict hygienic requirements and high-value processes.
The installation for animal blood plasma filtration and concentration reflects this capability: transforming a process challenge into a robust, traceable and scalable industrial solution.
Perinox supports companies from the technical definition of the process through to the integration of industrial solutions adapted to their operational, sanitary and production standards.
